This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Preview: Adient (ADNT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Adient (ADNT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
Auto Equipment Outlook: Technological & Cost Barriers Ahead
by Gargi Dam Kanunjna
The capacity to efficiently absorb development and manufacturing costs in a rapidly evolving space is the key to success for the Auto - Original Equipment industry.
Adient (ADNT) Down 15.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for February 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
The Zacks Analyst Blog Highlights: Goodyear Tire & Rubber, Adient, Penske Automotive, CNH Industrial and Lithia Motors
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Goodyear Tire & Rubber, Adient, Penske Automotive, CNH Industrial and Lithia Motors
Auto Stock Roundup: CNHI & LAD Beat on Earnings, GT, ADNT & PAG Miss on Both Counts
by Zacks Equity Research
Goodyear Tire (GT), Adient (ADNT) and Penske (PAG) report earnings & revenue miss while CNH Industrial (CNHI) and Lithia Motors (LAD) beat earnings and revenue estimates.
Adient (ADNT) Misses Q1 Earnings Estimates, Shares Down (Revised)
by Zacks Equity Research
Adient's (ADNT) earnings in first-quarter fiscal 2019 miss estimates on negative business performance due to launch inefficiencies.
New Strong Sell Stocks for February 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Adient (ADNT) Misses Q4 Earnings Estimates, Shares Down
by Zacks Equity Research
Adient's (ADNT) earnings in first-quarter fiscal 2019 miss estimates on negative business performance driven by launch inefficiencies.
Implied Volatility Surging for Adient (ADNT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
Adient (ADNT) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -35.42% and -0.27%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Adient (ADNT) Stock Options
by Zacks Equity Research
Adient (ADNT) needs investors to pay close attention to the stock based on moves in the options market lately.
Adient (ADNT) Surges: Stock Moves 7.8% Higher
by Zacks Equity Research
Adient (ADNT) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
New Strong Sell Stocks for December 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Should You Get Rid of Adient (ADNT) Now?
by Zacks Equity Research
Adient (ADNT) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Adient's (ADNT) Q4 Earnings Beat Estimates, Revenues Up
by Zacks Equity Research
The acquisition of Futuris and increase in volume aid Adient's (ADNT) revenue growth.
Adient (ADNT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 3.17% and 0.52%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Adient (ADNT) Q4 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for October 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Adient (ADNT) Benefits From Stabilization of SS&M Segment
by Zacks Equity Research
Adient's (ADNT) SS&M segment gains from its stabilization moves, which are likely to continue in the future.
Adient's (ADNT) Q3 Earnings Miss Estimates, Revenues Up
by Zacks Equity Research
For fiscal 2018, Adient (ADNT) anticipates revenues of around $17.5 billion, up from the prior guidance of $17-$17.2 billion.
New Strong Sell Stocks for July 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: